mycosesstudygroup.org
#
Course: Opportunistic Fungi in the Immunocompromised Patient
 You are at:
Online test available
Epidemiology of Fungal Infection and Disease
 
Table of Contents Next CME main Next 
IQ Option http://www.iqoption.cz V České republice
previous  Previous Next  Next

     
At-Risk Populations

Solid-Organ Transplant Recipients

Risk Factors Immunosuppressive therapy and corticosteroids, particularly when used to treat acute rejection, are once again the cause of the immune defect predisposing organtransplant recipients to fungal infection. Cyclosporine and tacrolimus specifically affect T lymphocytes by decreasing CD4+ helper cells and IL-2 synthesis. Underlying disease and the presence of immunomodulating viral infections such as CMV are also important risk factors affecting neutrophil and macrophage function. The extensive surgery and invasive intensive-care procedures involved in treatment of this patient population mean that environmental factors such as impaired host barriers are of paramount importance in the risk of infection.

The transplanted organ is rarely a source of fungal infection, although this has been reported.

Incidence and Mortality Serious fungal infections can follow solid-organ transplantation and are associated with high mortality (27% to 77%) [33]. Incidence and timing of the infection vary according to the immunosuppressive treatment and type of organ transplanted [29, 34]. Retrospective analyses of organ-transplant outcomes reveal significant levels of fungal infection [34]. In one center for liver transplantation, the rates of disseminated candidiasis, aspergillosis, and combined infection were 6.5%, 7.2%, and 2.6%, respectively. Mortality rate was 80%, with only 1 of the 11 patients with aspergillosis surviving [35]. In 200 episodes of serious infection in 73 heart-lung recipients, reported [36] fungal infections were 14% (12 episodes of candidiasis and 14 episodes of aspergillosis). Cryptococcal infection after solid-organ transplant has been estimated to occur in up to 4% of renal-transplant recipients, with a direct mortality of 36% [37]. Zygomycetes have been reported to cause infection in 1% to 9% of transplant patients, and infection with endemic mycoses depends on the geographic exposure of transplanted patients either before or after the transplant [33].





previous  Previous Next  Next

• •   You are at:
Epidemiology of Fungal Infection and Disease
   Interactions between Agent, Host, and Environment
   The Agent
   The Environment
   The Host
   At-Risk Populations
       The Cancer Patient
       Bone-Marrow Transplant Recipients
       Solid-Organ Transplant Recipients
       HIV-Infected Individuals
   Spotting the Patient at High Risk
   Timetable of Infection

Back to Contents


Course Number: V035B.043001

This CME Expires on July 1, 2003; no tests will be accepted after this date.

This course is accredited by The University of Pittsburgh School of Medicine, Center for Continuing Education




  Privacy Policy
Contact: mycosesstudygroup.org
Site Contents Copyright © 2007 mycosesstudygroup.org